FDA Fast-Tracks Lipocine’s LPCN 1148 for Sarcopeni...
Category : ODD/BTA/FTA Status 20 December 2024Lipocine Inc., a biopharmaceutical company leveraging its proprietary technology platform to augment...
Odd Bta Fta Status
US FDA Fast Tracks Sanofi's Combo Vaccines for Flu...
Category : ODD/BTA/FTA Status 12 December 2024The US Food and Drug Administration has granted Fast Track designation to two Sanofi combination vac...
Seres Therapeutics Receives Breakthrough Therapy D...
Category : ODD/BTA/FTA Status 11 December 2024Seres Therapeutics has announced the regulatory approval of SER-155, a treatment aimed at reducing b...
EpicentRx's AdAPT-001 TGFß Inhibitor Gains FDA Fas...
Category : ODD/BTA/FTA Status 10 December 2024EpicentRx, a privately held biopharmaceutical company, has announced that the US Food and Drug Admin...
US FDA Grants Breakthrough Therapy Designation to...
Category : ODD/BTA/FTA Status 14 November 2024US FDA grants breakthrough therapy designation to Johnson & Johnson’s nipocalimab to treat...
Latest Newsletter Post
-
TRYNGOLZA™ (olezarsen) Approved in..
20 December 2024
-
Sanofi, Teva's RELIEVE UCCD Phase 2..
20 December 2024
-
Bayer's Phase III QUASAR Study: Pos..
20 December 2024
-
FDA Fast-Tracks Lipocine’s LPCN 114..
20 December 2024
-
MannKind Reports Phase 3 INHALE-1 R..
19 December 2024
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com